A preliminary study of ribavirin plus interferon in the treatment for Chronic Hepatitis C.

被引：0
|
作者：
Bailey, BJ [1 ]
Meyer, DL [1 ]
机构：
[1] UNIV ALBERTA HOSP,DEPT MED,ROYAL ALEXANDRA HOSP,EDMONTON,AB T6G 2B7,CANADA
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1392 / 1392
页数：1
相关论文
共 50 条
  • [41] Interferon plus ribavirin in hemophiliacs with chronic hepatitis C nonresponder to interferon monotherapy.
    Tagliaferri, A
    Rossetti, G
    Franchini, M
    Pattacini, C
    Bertuzzo, D
    Capra, F
    De Maria, E
    Gandini, G
    BLOOD, 2002, 100 (11) : 710A - 710A
  • [42] Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant α-interferon
    Bresci, G
    Parisi, G
    Bertoni, M
    Scatena, F
    Capria, A
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (01) : 75 - 78
  • [43] Ribavirin plus human leucocyte interferon alpha for the treatment of interferon resistant chronic hepatitis C: A controlled trial
    Toccaceli, F
    Grimaldi, M
    Rosati, S
    Palazzini, E
    Laghi, V
    HEPATOLOGY RESEARCH, 1997, 8 (02) : 106 - 112
  • [44] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Rudolf E Stauber
    Harald Hofer
    Franz Hackl
    Kurt Schüze
    Christian Datz
    Karin Hegenbarth
    Wolfgang Jessner
    Petra Steindl-Munda
    Peter Ferenci
    Wiener Klinische Wochenschrift, 2004, 116 : 530 - 535
  • [45] Serum erythropoietin concentration increases during α-interferon and ribavirin combination treatment for chronic hepatitis C.
    Mangoni, ED
    Saviano, D
    Utili, R
    Adinolfi, LE
    Giordano, M
    Ruggiero, G
    HEPATOLOGY, 2001, 34 (04) : 417A - 417A
  • [46] Cost-effectiveness of interferon/ribavirin treatment among nonresponders to initial interferon therapy for chronic hepatitis C.
    Kim, WR
    Poterucha, JJ
    Dickson, ER
    Gross, JB
    HEPATOLOGY, 1998, 28 (04) : 231A - 231A
  • [47] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Stauber, RE
    Hofer, H
    Hackl, F
    Schütze, K
    Datz, C
    Hegenbarth, K
    Jessner, W
    Steindl-Munda, P
    Ferenci, P
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (15-16) : 530 - 535
  • [48] Triple combination of interferon A-2b, ribavirin, and amantadine for treatment of chronic hepatitis C.
    Younossi, ZM
    Mullen, KD
    Hodnick, S
    McCormick, M
    Bringman, D
    Barnes, DS
    Carey, WD
    McCullough, AJ
    Easley, K
    Yen-Lieberman, B
    GASTROENTEROLOGY, 2000, 118 (04) : A1501 - A1501
  • [49] Combination therapy interferon plus amantadine in chronic active hepatitis C. A multicentric randomised study: Preliminary reports
    Tabone, M
    Del Mastro, B
    Bonardi, R
    Andreoni, M
    Manca, A
    Calleri, G
    Cariti, G
    Cusumano, S
    Brunello, F
    HEPATOLOGY, 1999, 30 (04) : 628A - 628A
  • [50] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
12345